Dry Eye Syndromes
Showing 9976 - 10000 of >10,000
Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial
Completed
- Recurrent Thyroid Gland Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- Selumetinib
-
Tampa, Florida
- +5 more
Dec 2, 2016
Keratoconjunctivitis Sicca Trial in Andover (R348 Ophthalmic Solution, 0.2%, R348 Ophthalmic Solution, 0.5%, R348 Ophthalmic
Completed
- Keratoconjunctivitis Sicca
- R348 Ophthalmic Solution, 0.2%
- +3 more
-
Andover, MassachusettsAndover Eye Associates
Jul 31, 2014
NSCLC, Thoracic Surgery Trial (Indocyanine Green)
Withdrawn
- Non-small Cell Lung Cancer
- Thoracic Surgery
- Indocyanine Green
- (no location specified)
Jun 1, 2017
Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Boston (Bevacizumab, erlotinib, Sulindac)
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Bevacizumab
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 15, 2017
HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (biological, procedure, drug, other)
Completed
- HER2-positive Breast Cancer
- +3 more
- HER-2/neu peptide vaccine
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017
Post-operative Pain Trial in Phoenix, Pasadena, Austin (Buprenorphine Sublingual Spray, Placebo)
Terminated
- Post-operative Pain
- Buprenorphine Sublingual Spray
- Placebo
-
Phoenix, Arizona
- +2 more
Aug 3, 2017
Transfusional Iron Overload, ß-thalassemia Major, Pediatric Rare Anemia Trial in France, Italy (Deferasirox)
Completed
- Transfusional Iron Overload
- +2 more
-
Lyon, France
- +3 more
Feb 12, 2017
Recurrent Glioblastoma Multiforme, Malignant Glioma, Adult Brain Tumor Trial in Durham (Vorinostat, Bevacizumab)
Completed
- Recurrent Glioblastoma Multiforme
- +2 more
-
Durham, North CarolinaDuke Cancer Center
Jan 20, 2017
Dacryocystorhinostomy, Ectropion, Entropion Trial in Ibiza (Novosyn® Quick, Vicryl® Rapid)
Withdrawn
- Dacryocystorhinostomy
- +5 more
- Novosyn® Quick
- Vicryl® Rapid
-
Ibiza, Baleares, SpainHospital Can Misses
Jun 9, 2016
OCD Trial in Boston (D-Cycloserine, Placebo)
Completed
- Obsessive-Compulsive Disorder
- D-Cycloserine
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Feb 24, 2017
Amblyopia Trial in Baltimore (Levodopa/Carbidopa, Placebo, Patching)
Obstructive Sleep Apnea Syndrome in Glaucoma
Terminated
- Obstructive Sleep Apnea Syndrome
- Glaucoma
- nCPAP treatment
-
Basel, BS, SwitzerlandUniversity Hospital Basel, Eye Clinic
Oct 1, 2015
Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma Trial in Japan (Vandetanib 300mg)
Completed
- Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma
- Vandetanib 300mg
-
Fukuoka-shi, Japan
- +3 more
Oct 11, 2016
MDS Trial in Beijing (Microtransplantation)
Completed
- Myelodysplastic Syndromes
- Microtransplantation
-
Beijing, Beijing, ChinaAffiliated Hospital of Academy of Military Medical Sciences
Jul 12, 2016
Relapsed Multiple Myeloma Trial in Canada, United States (Carfilzomib, Lenalidomide, Dexamethasone)
Completed
- Relapsed Multiple Myeloma
- Carfilzomib
- +2 more
-
Long Beach, California
- +11 more
Apr 28, 2017
Malignant Tumors of Brain Trial in Durham, Houston (PEP-3 vaccine, sargramostim, Temozolomide)
Completed
- Malignant Neoplasms of Brain
- PEP-3 vaccine
- +2 more
-
Durham, North Carolina
- +1 more
Dec 2, 2016
Retinal Hemorrhage, Macular Degeneration Trial in Royal Oak (vitrectomy with subretinal lucentis)
Withdrawn
- Retinal Hemorrhage
- Macular Degeneration
- vitrectomy with subretinal lucentis
-
Royal Oak, MichiganWilliam Beaumont Hospital
Aug 4, 2016
Cluster Headache Trial in Trondheim (Botulinum Toxin Type A 25 IU, Botulinum Toxin Type A 50 IU)
Completed
- Cluster Headache
- Botulinum Toxin Type A 25 IU
- Botulinum Toxin Type A 50 IU
-
Trondheim, NorwayDepartment of Neuroscience, Norwegian University of Science and
Mar 16, 2017
Benign Prostatic Hyperplasia Trial in Japan (Tadalafil, Placebo, Alpha1 Blocker)
Lymphoma Trial in Worldwide (Inotuzumab Ozogamicin (CMC-544))
Completed
- Lymphoma
- Inotuzumab Ozogamicin (CMC-544)
-
Birmingham, Alabama
- +41 more
Oct 27, 2017